/THIS NEWS RELEASE, PROVIDED PURSUANT TO APPLICABLE CANADIAN
REQUIREMENTS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR
DISSEMINATION IN THE UNITED
STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES
DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER
THE UNITED STATES SECURITIES ACT
OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE
OFFERED OR SOLD IN THE UNITED
STATES OR TO U.S. PERSONS ABSENT REGISTRATION OR APPLICABLE
EXEMPTION FROM REGISTRATION REQUIREMENTS./
VANCOUVER, Feb. 3, 2020 /CNW/ - Geyser Brands Inc.
(TSX-V: GYSR) ("Geyser Brands" or the
"Company") is pleased to announce that, with the recent
acquisition of Solace Management Inc., the company's total revenues
for the quarter ending December 31,
2019 have significantly increased. Upon receiving a
sales license from Health Canada which is anticipated shortly, the
company is ready to offer tinctures, capsules, topical products,
infused all-natural consumer products into the Canadian and global
markets. This is expected to result in substantial growth in the
Geyser's global sales and distribution.
"It is very encouraging to see significant growth in
manufacturing and distribution of our branded consumer products
ranging from our natural product certified (Natural
Product Number (NPN)) topical pain products,
to beauty care, to our hemp based pet line. Our branded all-natural
consumer products have already started gaining recognition and
major traction in the global consumer markets, and among large
national retail chains." commented Brad
Kersch, chief operations officer.
Rob Trenaman has resigned from
the Board of Directors. The Company thanks Mr. Trenaman for his
contributions and wishes him all the best in future endeavors.
About Geyser Brands
Geyser Brands Inc. develops consumer product brands in the
health and wellness sector that use hemp and CBD as a value-added
ingredient. These involve next-generation formulas that focus on
the mix of cannabinoids for specific conditions such as insomnia,
anxiety and pain.
Proprietary delivery technologies include all natural
nano-technology, slow-release mechanisms and non-molecule degrading
baking processes. In anticipation of coming edibles legislation,
and with its Health Canada approved Licensed Production Facility,
Geyser Brands has 15,000 square feet in two GMP facilities in
Vancouver, BC.
For more information, visit Geyser Brands' website at
www.geyserbrands.com.
On Behalf of the Board of Directors
"Andreas Thatcher"
____________________________________
Andreas Thatcher
Director and CEO
athatcher@geyserbrands.com
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES
PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX
VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR
ACCURACY OF THIS RELEASE.
This news release contains forward‐looking
statements and forward‐looking information within the
meaning of applicable securities laws. These statements relate to
future events or future performance. All statements other than
statements of historical fact may be forward‐looking
statements or information. Forward‐looking statements
and information are often, but not always, identified by the use of
words such as "appear", "seek", "anticipate", "plan", "continue",
"estimate", "approximate", "expect", "may", "will", "project",
"predict", "potential", "targeting", "intend", "could", "might",
"should", "believe", "would" and similar expressions.
Forward-looking statements and information are provided for
the purpose of providing information about the current expectations
and plans of management of the Company relating to the future.
Readers are cautioned that reliance on such statements and
information may not be appropriate for other purposes, such as
making investment decisions. Since forward‐looking
statements and information address future events and conditions, by
their very nature they involve inherent risks and uncertainties.
Actual results could differ materially from those currently
anticipated due to a number of factors and risks. These include,
but are not limited to, the risks associated with the marijuana
industry in general such as operational risks in growing;
competition; incorrect assessment of the value and potential
benefits of various transactions; ability to access sufficient
capital from internal and external sources; failure to obtain
required regulatory and other approvals and changes in legislation,
including but not limited to tax laws and government regulations.
Accordingly, readers should not place undue reliance on the
forward‐looking statements, timelines and information
contained in this news release. Readers are cautioned that the
foregoing list of factors is not exhaustive. Additional
information relating to Geyser is available
at www.sedar.com.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES
PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX
VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR
ACCURACY OF THIS RELEASE.
SOURCE Geyser Brands Inc.
